1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. COEPTIS THERAPEUTICS HOLDINGS INC

Coeptis Therapeutics Holdings Inc

XNAS: COEP

Download real time

9.38 0.07 (0.75%)

31.53% Fall from 52W High

12,086 XNAS Volume

XNAS 28 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
12S
5W
4O
1T
30.4

Market Cap

Below industry Median
-2.6

PE TTM

Negative PE TTM
-0.1

PEG TTM

PEG TTM is negative
6.3

Price to Book

High in industry
0.1

Beta 1Year

Very Low volatility


Insider Trading disclosures for Coeptis Therapeutics Holdings Inc

The latest disclosure was made by Philippe Deschamps in Coeptis Therapeutics Holdings Inc where a trade of 5,700 Non-qualified Stock Options (right to buy) done was reported to US exchanges on March 4, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Philippe Deschamps Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2025 5,700 8,950 - - Non-qualified Stock Options (right to buy)
Brian Cogley Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2025 10,000 22,500 - - Non-Qualified Stock Options (right to buy)
Christopher Cochran Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2025 5,700 8,950 - - Non-qualified Stock Options (right to buy)
Tara Maria DeSilva Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2025 5,700 8,950 - - Non-qualified Stock Options (right to buy)
Christine Sheehy VP Compliance and Secy Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2025 1,000 13,500 - - Non-Qualified Stock Options (right to buy)
Daniel Yerace Director, VP of Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2025 5,000 25,000 - - Non-Qualified Stock Options (right to buy)
David Mehalick Director, CEO and President, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2025 28,875 200,125 - - Non-Qualified Stock Options (right to buy)
Christopher Calise Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2025 5,700 8,950 - - Non-qualified Stock Options (right to buy)
Gene Salkind Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2025 5,700 8,950 - - Non-qualified Stock Options (right to buy)
Maria Tara DeSilva Director Purchase of securities on an exchange or from another person at price $ 0.56 per share. 12 Jan 2024 466 30,466 - 0.6 261 Common Stock
DeSilva Maria Tara Director Purchase of securities on an exchange or from another person at price $ 0.58 per share. 12 Jan 2024 1,800 32,266 - 0.6 1,044 Common Stock
Brian Cogley Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.67 per share. 10 Jan 2024 5,000 30,000 - 0.7 3,350 Common Stock
Mehalick David Director, CEO and President, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.67 per share. 05 Jan 2024 6,000 2,768,611 - 0.7 4,020 Common Stock
Daniel Yerace Director, VP of Operations Purchase of securities on an exchange or from another person at price $ 0.69 per share. 05 Jan 2024 10,850 1,071,455 - 0.7 7,487 Common Stock
Christopher Cochran Director Purchase of securities on an exchange or from another person at price $ 0.77 per share. 05 Jan 2024 7,000 37,000 - 0.8 5,390 Common Stock
Salkind Gene Director Purchase of securities on an exchange or from another person at price $ 0.69 per share. 05 Jan 2024 11,600 284,056 - 0.7 8,004 Common Stock
David Mehalick Director, CEO and President, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.66 per share. 05 Jan 2024 14,004 2,782,615 - 0.7 9,243 Common Stock
David Mehalick Director, CEO and President, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.69 per share. 05 Jan 2024 5,050 2,762,611 - 0.7 3,485 Common Stock
David Mehalick Director, CEO and President, Ten Percent Owner Gift of securities by or to the insider at price $ 0.00 per share. 07 Dec 2023 700,000 2,757,561 - 0 Common Stock
Gene Salkind Director Purchase of securities on an exchange or from another person at price $ 0.91 per share. 25 Aug 2023 28,638 28,638 - 0.9 26,061 Common Stock
Gene Salkind Director Purchase of securities on an exchange or from another person at price $ 1.01 per share. 25 Aug 2023 4,006 4,046 - 1.0 4,046 Common Stock
Christopher Calise Director Purchase of securities on an exchange or from another person at price $ 0.94 per share. 23 Aug 2023 2,582 1,464,897 - 0.9 2,419 Common Stock
Christopher Calise Director Purchase of securities on an exchange or from another person at price $ 0.94 per share. 23 Aug 2023 9,000 1,462,315 - 0.9 8,460 Common Stock
Christine Sheehy Director, CFO and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2023 200,000 200,000 - - Incentive Stock Options (right to buy)
Tara Maria DeSilva Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2023 30,000 30,000 - - Non-qualified Stock Options (right to buy)
Christopher Cochran Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2023 30,000 30,000 - - Non-qualified Stock Options (right to buy)
David Mehalick Director, CEO and President, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2023 250,000 250,000 - - Incentive Stock Options (right to buy)
Daniel Yerace Director, VP of Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2023 200,000 200,000 - - Incentive Stock Options (right to buy)
Philippe Deschamps Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2023 30,000 30,000 - - Non-qualified Stock Options (right to buy)
Gene Salkind Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2023 30,000 30,000 - - Non-qualified Stock Options (right to buy)
Christopher Calise Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2023 30,000 30,000 - - Non-qualified Stock Options (right to buy)
David Mehalick Director, CEO and President, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2023 375,000 375,000 - - Non-qualified Stock Options (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters